Iqvia launches the clinical data analytics suite (cdas) to enable smarter, faster clinical trials

Research triangle park, n.c.--(business wire)--iqvia™ (nyse: iqv) today introduced clinical data analytics suite (cdas), a new saas-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use. this produces a scalable repository, that helps meet regulatory requirements, for stakeholders to investigate operational and clinical data. it also drives faster predictive analytics using ai/ml,
IQV Ratings Summary
IQV Quant Ranking